University Hospital of Zürich

Principle Investigator: PD Dr. Steve Pascolo

Expertise: RNA-based therapeutics

Steve Pascolo is a co-founder of the mRNA vaccine compant, Curevac. The Pascolo lab utilizes mouse models and cell assays (using mammalian cell lines of buffy coats). With ample experience in cell biology and immunology and a recently developed mRNA oligonucleotide translation assay, they are the ideal team for demonstrating the power of NEWmRNA on vaccinations and gene therapy.